Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: AstraZeneca PLC

Market Cap 280B 242B 222B 209B 392B 26,487B 396B 2,628B 1,027B 12,971B 1,052B 1,029B 44,883B P/E Ratio 2026 *
22.8x
P/E Ratio 2027 * 19.8x
Enterprise Value 300B 258B 238B 223B 419B 28,339B 423B 2,812B 1,098B 13,878B 1,125B 1,101B 48,022B EV / Sales 2026 *
4.74x
EV / Sales 2027 * 4.36x
Free-Float
96.63%
Yield 2026 *
1.85%
Yield 2027 * 1.95%
1 day-1.45%
1 week-4.00%
Current month-2.51%
1 month-2.17%
3 months-6.86%
6 months-1.30%
Current year-2.00%
1 week 1,659.5
Extreme 1659.5
1,744.5
1 month 1,601.5
Extreme 1601.5
1,775.5
Current year 1,601.5
Extreme 1601.5
1,925.5
1 year 1,316
Extreme 1316
1,925.5
3 years 1,226
Extreme 1226
1,925.5
5 years 960.3
Extreme 960.3
1,925.5
10 years 450
Extreme 450
1,925.5
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Chief Operating Officer 55 01/06/2015
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.45%-4.00% - - 280B
-0.23%-1.64%+39.97%+149.01% 1,010B
-1.69%+2.02%+52.59%+44.66% 580B
-2.61%-0.38%+16.43%+63.53% 402B
-0.46%0.00%+21.28%+19.14% 330B
-1.52%+2.45%+24.75%+33.03% 281B
-0.57%+5.00%-42.66%-48.28% 197B
+0.15%+2.62%+20.04%+55.31% 192B
-0.38%-2.86%+12.28%+57.52% 156B
-0.17%+2.13%+7.23%-34.18% 149B
Average -0.86%+1.23%+16.88%+37.75% 366.43B
Weighted average by Cap. -0.90%+1.35%+27.26%+67.48%

Financials

2026 *2027 *
Net sales 63.32B 54.58B 50.23B 47.12B 88.52B 5,985B 89.4B 594B 232B 2,931B 238B 233B 10,141B 67.16B 57.88B 53.27B 49.97B 93.87B 6,347B 94.81B 630B 246B 3,108B 252B 247B 10,755B
Net income 12.43B 10.71B 9.86B 9.25B 17.37B 1,175B 17.55B 117B 45.53B 575B 46.64B 45.66B 1,991B 14.09B 12.14B 11.17B 10.48B 19.69B 1,331B 19.89B 132B 51.6B 652B 52.86B 51.74B 2,256B
Net Debt 19.6B 16.89B 15.54B 14.58B 27.39B 1,852B 27.67B 184B 71.78B 907B 73.54B 71.98B 3,138B 12.67B 10.92B 10.05B 9.43B 17.71B 1,197B 17.88B 119B 46.4B 586B 47.54B 46.53B 2,029B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
15/06/26 1,669.50 kr -1.45% 508,660
12/06/26 1,694.00 kr -1.71% 440,089
11/06/26 1,723.50 kr +0.64% 243,357
10/06/26 1,712.50 kr -0.72% 252,423
09/06/26 1,725.00 kr -0.81% 293,454
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
180.70USD
Average target price
220.99USD
Spread / Average Target
+22.30%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!